The market for CBD products has outgrown the dispensary and the next stage of growth is happening at the retail space.

According to a new report by BDS Analytics and Arcview Market Research entitled “CBD: Cannabinoids Escape the Dispensary”, the US CBD market is expected to hit US$20 billion by 2024. Sales at dispensaries and pharmacies are projected to reach US$5.3 billion and $US2.2 billion, respectively. Sales in non-cannabis-related retail distribution channels are expected to take the biggest share (63 percent) of CBD infused product sales to total US$12.6 billion.

This latest forecast shows that CBD has truly gone mainstream. As part of the exploding US$4.2 trillion health and wellness market, the non-psychoactive cannabinoid’s ability to relieve pain, inflammation and anxiety has given rise to a wide range of CBD infused products that are being marketed as essential aspects of a healthy lifestyle and ideal beauty regimen. Even CBD pet care lines are finding their way to store shelves. Major retailers such as CVS Pharmacy (NYSE:CVS), Walgreens (NASDAQ:WBA), Rite Aid (NYSE:RAD) and Kroger (NYSE:KR) now carry CBD topicals including creams, sprays, roll-ons, oils, lotions and salves.

All of this was made possible by the removal of major legal barriers in the United States in the past year. In December 2018, the US Farm Bill was passed, effectively legalizing the production of hemp and the interstate transport of hemp-derived CBD products. Earlier in the year, the federal government had removed hemp-derived CBD from the Controlled Substance Act.

Now that those barriers are down and the country’s major retail chains are on board, the market is experiencing a flurry of co-branding partnerships between CBD companies and top brands.

CBD products entering the mainstream

Following in the footsteps of retail giants like Walgreens and Kroger, clothing and beauty retail brands are now getting in on the action, signing agreements with cannabis companies to give shelf space to CBD consumer packaged goods.

Urban Outfitters (NASDAQ:URBN) has a deal with CBD For Life, a brand owned by dispensary operator iAnthus Capital Holdings (OTCQX:ITHUF), to carry CBD infused products at select stores in California and New York as well as on the retailer’s e-commerce platform. Cosmetics retailer Ulta Beauty (NASDAQ:ULTA) announced it plans to join other beauty companies like Sephora in carrying CBD skin-care products.

Early in 2019, Authentic Brands Group (ABG) inked a long-term revenue-sharing deal with cannabis company Tilray (NASDAQ:TLRY) to develop and distribute CBD products globally. Under the agreement, Tilray will pay up to US$250 million over a 10-year period for 49 percent of the net revenue of co-branded product sales. ABG has several key brands under its umbrella, including Aeropostale, Juicy Couture, Jones New York and World Golf Hall-of-Famer Greg Norman’s brand.

In a related deal, Green Growth Brands (CSE:GGB,OTCQB:GGBXF) is partnering with Tilray to produce a line of CBD-infused products for active men and women under the Greg Norman brand, which is available in over 3,000 retail locations across the United States. “I played professional golf for 40 years, hitting more than five million golf balls that have caused significant wear and tear on my body,” said Greg Norman. “Having been through it all, on the golf course and in business, I am thrilled to partner with GGB Beauty to distribute Greg Norman® CBD products throughout the country.”

Green Growth Brands also has a partnership agreement with retailer Designer Brands (NYSE:DBI) (formerly DSW) to stock nearly 100 US stores with Seventh Sense Botanical Therapy branded CBD infused personal care products. “We have seen recent shifts in consumer behavior accelerate changes in the retail industry,” said Roger Rawlins, CEO of Designer Brands. “North America’s widespread adoption of the use of CBD products is one of the best examples of these shifts, and we could not be more excited about our partnership with Green Growth Brands and the introduction of their products to our customers.” Seventh Sense products are also being distributed by major retail brands including Abercrombie & Fitch (NYSE:ANF) in more than 160 stores across the United States.

CBD products creating co-branding opportunities

These co-branded collaborations have many benefits for CBD product companies in a highly competitive, emerging sector in consumer packaged goods. “First of all, such partnerships bring validation to CBD as a product category in this marketspace and legitimize CBD infused products into mainstream consumption,” Peter Horvath, CEO of Green Growth Brands, told Investing News Network. Horvath is a retail veteran who has served in critical senior management roles for brands such as Victoria’s Secret, DSW and Limited Brands. “The cannabis industry as a whole has encountered many roadblocks to raising capital, however these partnerships signal to investors that major retailers recognize the growing consumer demand for CBD products.”

Obtaining a spot on the shelf is the holy grail for any emerging consumer goods company, and even more so for cannabis companies. The brand recognition provided by major retailers like Abercrombie & Fitch is an important step towards establishing market share and the ability to put your own brand in front of the current target market is a huge opportunity. Companies capable of establishing relationships with retailers and building brand awareness with consumers through hemp-derived CBD are paving the way for cannabis-derived products while capturing a coveted first-mover advantage.


The growing mainstream demand for CBD based consumer products made possible by the US Farm Bill has led to “wellness” as a third category in the cannabis market alongside medical and recreational. Co-branding partnerships offer CBD product companies an effective route to brand recognition and the potential to capture a great share of the market.

This INNSpired article was written according to INN editorial standards to educate investors.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less